Federated Hermes, Inc. 13D and 13G filings for aTyr Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-08 1:38 pm Unchanged | 2024-12-31 | 13G | aTyr Pharma, Inc. ATYR | FEDERATED HERMES INC. FHI | 14,666,600 17.470% | 0 (Unchanged) | Filing |
| 2024-10-07 1:36 pm Purchase | 2024-09-30 | 13G | aTyr Pharma, Inc. ATYR | FEDERATED HERMES INC. FHI | 14,666,600 19.350% | 4,497,000 (+44.22%) | Filing |
| 2024-01-18 10:17 am Purchase | 2023-12-31 | 13G | aTyr Pharma, Inc. ATYR | FEDERATED HERMES INC. FHI | 10,169,600 17.370% | 4,938,000 (+94.39%) | Filing |
| 2023-02-01 10:29 am Purchase | 2022-12-31 | 13G | aTyr Pharma, Inc. ATYR | FEDERATED HERMES INC. FHI | 5,231,600 18.030% | 5,231,600 (New Position) | Filing |